6-oxo-morphinane oximes: pharmacology, chemistry and analytical application. 2004

A Gergely, and K Gyimesi-Forrás, and P Horváth, and S Hosztafi, and J Kökösi, and P I Nagy, and Gy Szász, and A Szentesi
Department of Pharmaceutical Chemistry, Semmelweis University, H-1092 Budapest, Högyes E. u. 9. Hungary. gerand@hogyes.sote.hu.

The permanent therapeutic importance of morphine derivatives in pain treatment has inspired continual synthetic efforts to modify the rigid pentacyclic systems in search for new selective analgesic agents. As a result, several morphinane oximes have been synthesized recently, which have the additional advantage of possessing an oxime group that can provide a method for selective determination of opiate alkaloids in biological matrices. The oximes of hydrocodone and oxycodone have stronger analgesic effect than the parent ketones and they also proved to be effective in preventing the respiratory depressant and hypotensive actions of fentanyl. In this work a review is given on the present status of oxime pharmacology, chemistry and analysis and also the oxime and O-methyl oxime formation of 6-oxo-morphinanes with therapeutic interest (codeinone, oxycodone, hydrocodone and 14-OH-codeinone). The oxime formation was monitored by reversed-phase HPLC and the chromatographic properties of oxime isomers have been characterized. The assignation of the individual isomers isolated by preparative HPLC was performed by (1)H NMR spectroscopy based on the chemical shift differences of the 5-H signals. In this way the isomeric ratio in the oxime products could also be determined. It was found that in the case of Delta(7)-6-oxo-morphinanes, depending on the substituents, the formation of the Z-isomer highly dominates (73-96%) over that of the E-isomer. However, for the saturated 7,8-(dihydro) derivatives the E-isomer is definitely preferred (>98%). In conclusion of a survey on the theoretical background of oxime isomerism, the conformational differences between the saturated and unsaturated morphinane systems were found responsible for the different E/Z ratios. On the basis of the isomeric ratio and the on-line CD and UV spectra of the pure isomers, the molar ellipticities and absorbancies of the isomers were calculated by a parameter estimation method.

UI MeSH Term Description Entries
D009019 Morphinans Compounds based on a partially saturated iminoethanophenanthrene, which can be described as ethylimino-bridged benzo-decahydronaphthalenes. They include some of the OPIOIDS found in PAPAVER that are used as ANALGESICS. Morphinan
D009020 Morphine The principal alkaloid in opium and the prototype opiate analgesic and narcotic. Morphine has widespread effects in the central nervous system and on smooth muscle. Morphine Sulfate,Duramorph,MS Contin,Morphia,Morphine Chloride,Morphine Sulfate (2:1), Anhydrous,Morphine Sulfate (2:1), Pentahydrate,Oramorph SR,SDZ 202-250,SDZ202-250,Chloride, Morphine,Contin, MS,SDZ 202 250,SDZ 202250,SDZ202 250,SDZ202250,Sulfate, Morphine
D010091 Oximes Compounds that contain the radical R2C Aldoximes,Hydroxyimino Compounds,Ketoxime,Ketoximes,Oxime,Compounds, Hydroxyimino
D002851 Chromatography, High Pressure Liquid Liquid chromatographic techniques which feature high inlet pressures, high sensitivity, and high speed. Chromatography, High Performance Liquid,Chromatography, High Speed Liquid,Chromatography, Liquid, High Pressure,HPLC,High Performance Liquid Chromatography,High-Performance Liquid Chromatography,UPLC,Ultra Performance Liquid Chromatography,Chromatography, High-Performance Liquid,High-Performance Liquid Chromatographies,Liquid Chromatography, High-Performance

Related Publications

A Gergely, and K Gyimesi-Forrás, and P Horváth, and S Hosztafi, and J Kökösi, and P I Nagy, and Gy Szász, and A Szentesi
October 2002, Analytical and bioanalytical chemistry,
A Gergely, and K Gyimesi-Forrás, and P Horváth, and S Hosztafi, and J Kökösi, and P I Nagy, and Gy Szász, and A Szentesi
January 1973, Annual review of pharmacology,
A Gergely, and K Gyimesi-Forrás, and P Horváth, and S Hosztafi, and J Kökösi, and P I Nagy, and Gy Szász, and A Szentesi
July 1915, Science (New York, N.Y.),
A Gergely, and K Gyimesi-Forrás, and P Horváth, and S Hosztafi, and J Kökösi, and P I Nagy, and Gy Szász, and A Szentesi
December 1999, Guang pu xue yu guang pu fen xi = Guang pu,
A Gergely, and K Gyimesi-Forrás, and P Horváth, and S Hosztafi, and J Kökösi, and P I Nagy, and Gy Szász, and A Szentesi
January 2009, Journal of AOAC International,
A Gergely, and K Gyimesi-Forrás, and P Horváth, and S Hosztafi, and J Kökösi, and P I Nagy, and Gy Szász, and A Szentesi
January 2022, Critical reviews in analytical chemistry,
A Gergely, and K Gyimesi-Forrás, and P Horváth, and S Hosztafi, and J Kökösi, and P I Nagy, and Gy Szász, and A Szentesi
September 2020, Foods (Basel, Switzerland),
A Gergely, and K Gyimesi-Forrás, and P Horváth, and S Hosztafi, and J Kökösi, and P I Nagy, and Gy Szász, and A Szentesi
February 1977, Journal of pharmaceutical sciences,
A Gergely, and K Gyimesi-Forrás, and P Horváth, and S Hosztafi, and J Kökösi, and P I Nagy, and Gy Szász, and A Szentesi
June 2003, Analytical and bioanalytical chemistry,
A Gergely, and K Gyimesi-Forrás, and P Horváth, and S Hosztafi, and J Kökösi, and P I Nagy, and Gy Szász, and A Szentesi
September 2010, Guang pu xue yu guang pu fen xi = Guang pu,
Copied contents to your clipboard!